title: Gabapentin pharmacotherapy for antipsychotic-induced akathisia: single-patient experiment and case report.
abstract: This clinical study reports upon the efficacy of gabapentin (Neurontin) for treating severe akathisia (3 on the Barnes Akathisia Rating Scale) in two patients receiving quetiapine (Seroquel), one of whom also received olanzapine (Zyprexa) for a short period. The first patient participated in an open-label experiment in which the bedtime dose of gabapentin was discontinued three times at intervals 1 week apart, resulting in severe akathisia which was quickly terminated by taking his usual 1200 mg gabapentin dose. This patient was also taking high doses of two benzodiazepines and a beta blocker, without therapeutic effect upon his akathisia; only gabapentin was efficacious. The second case is a report of a woman taking a high dose of quetiapine for anxiety who experienced severe akathisia which was relieved by taking 1200 mg of gabapentin. Possible mechanisms of action of gabapentin are discussed. Particular attention is drawn to the difference between neuroleptic-induced akathisia and the neurological condition of restless legs syndrome.
authors.affiliation: Associate Clinical Professor of Psychiatry, Columbia University and New York State Psychiatric Institute, New York, USA.
authors.forename: Maria A
authors.initials: MA
authors.lastname: Sullivan
authors.affiliation: Robert Wilbur Associates, 125 West 96th Street, Suite 6K, New York, NY 10025, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Wilbur
keywords: Barnes Akathisia Rating Scale; akathisia; antipsychotics; clonazepam; diazepam; gabapentin; neuroleptics; olanzapine; quetiapine; restless legs syndrome (RLS); timolol maleate